Open Access
| Issue |
Med Sci (Paris)
Volume 35, Number 3, Mars 2019
|
|
|---|---|---|
| Page(s) | 207 - 209 | |
| Section | Le Magazine | |
| DOI | https://doi.org/10.1051/medsci/2019043 | |
| Published online | 01 April 2019 | |
- Anderson KG, Stromnes IM, Greenberg PD. Obstacles posed by the tumor microenvironment to T cell activity: A case for synergistic therapies. Cancer Cell 2017 ; 31 : 311–325. [CrossRef] [PubMed] [Google Scholar]
- Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature 2017 ; 541 : 321–330. [CrossRef] [PubMed] [Google Scholar]
- Debets R, Donnadieu E, Chouaib S, Coukos G. TCR-engineered T cells to treat tumors: Seeing but not touching?. Semin Immunol 2016 ; 28 : 10–21. [Google Scholar]
- Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science 2015 ; 348 : 74–80. [Google Scholar]
- Herbst RS, Soria JC, Kowanetz M, et al. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients. Nature 2014 ; 515 : 563–567. [CrossRef] [PubMed] [Google Scholar]
- Salmon H, Donnadieu E. La matrice extracellulaire : un obstacle au contact entre les lymphocytes T et les cellules tumorales. Med Sci (Paris) 2012 ; 28 : 824–826. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Salmon H, Franciszkiewicz K, Damotte D, et al. Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors. J Clin Invest 2012 ; 122 : 899–910. [CrossRef] [PubMed] [Google Scholar]
- Bougherara H, Mansuet-Lupo A, Alifano M, et al. Real-time imaging of resident T cells in human lung and ovarian carcinomas reveals how different tumor microenvironments control T lymphocyte migration. Front Iimmunol 2015 ; 6 : 500. [Google Scholar]
- Mantovani A, Marchesi F, Malesci A, et al. Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol 2017 ; 14 : 399–416. [Google Scholar]
- Peranzoni E, Lemoine J, Vimeux L, et al. Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment. Proc Natl Acad Sci USA 2018 ; 115 : E4041–E4050. [CrossRef] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.